查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1977914

2026-2034年全球足底筋膜炎治療市場規模、佔有率、趨勢和成長分析報告

Global Plantar Fasciitis Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計足底筋膜炎治療市場將從 2025 年的 35 億美元成長到 2034 年的 238.6 億美元，2026 年至 2034 年的複合年成長率為 23.76%。

由於足部疾病、運動傷害和肥胖相關疾病的發生率不斷上升，全球足底筋膜炎治療市場正在擴張。足底筋膜炎是足跟疼痛的常見原因，特別常見於運動員和老年人。人們對早期診斷和治療方案（例如矯形器、物理治療、藥物治療和微創手術）的認知不斷提高，推動了市場成長。此外，人們參與體育鍛煉的增加也促進了對治療方案需求的成長。

診斷影像技術和治療設備的進步正在推動市場發展。包括衝擊波療法和再生醫學在內的創新治療方法的廣泛應用，正在改善患者的治療效果。此外，人們對非手術治療方法的日益重視以及鞋類技術的進步也對市場需求產生了積極影響。醫療機構正著力預防醫學和復健計劃，以降低復發率。

未來，在生物製藥和個人化治療方案的推動下，市場預計將持續成長。新興國家醫療基礎設施的擴張將進一步加速市場普及。此外，醫療費用支出在肌肉骨骼疾病方面的增加以及保險覆蓋範圍的擴大也將發揮重要作用。隨著疼痛管理和組織再生研究的進展，足底筋膜炎治療市場有望持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球足底筋膜炎治療市場：依類型分類

  • 市場分析、洞察與預測
  • 藥物治療
  • 矯正器具
  • 衝擊波療法
  • 外科手術
  • 其他

第5章：全球足底筋膜炎治療市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第6章 全球足底筋膜炎治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Pfizer Inc
    • Algeo Ltd
    • Otto Bock SE & Co
    • Hanger Inc
    • Bayer
    • GlaxoSmithKline Plc
    • Superfeet Worldwide Inc
    • Bauerfeid AG
    • KGaA（Otto Bock Holding）
    • Sanofi
    • Group（Dr. Scholl'S）
簡介目錄
Product Code: VMR112113821

The Plantar Fasciitis Treatment Market size is expected to reach USD 23.86 Billion in 2034 from USD 3.50 Billion (2025) growing at a CAGR of 23.76% during 2026-2034.

The Global Plantar Fasciitis Treatment Market is expanding due to the rising incidence of foot disorders, sports injuries, and obesity-related conditions. Plantar fasciitis is a common cause of heel pain, particularly among athletes and aging populations. Growing awareness about early diagnosis and treatment options such as orthotics, physiotherapy, medications, and minimally invasive procedures is supporting market growth. Increasing participation in physical activities also contributes to higher demand for treatment solutions.

Technological advancements in diagnostic imaging and therapeutic devices are key drivers for the market. The availability of innovative treatments, including shockwave therapy and regenerative medicine, is enhancing patient outcomes. Additionally, the increasing focus on non-surgical treatment methods and improved footwear technology is positively influencing demand. Healthcare providers are emphasizing preventive care and rehabilitation programs to reduce recurrence rates.

In the future, the market is expected to witness continued growth supported by advancements in biologics and personalized treatment approaches. Expanding healthcare infrastructure in emerging economies will further accelerate adoption. Rising healthcare expenditure and insurance coverage for musculoskeletal disorders will also play a vital role. As research in pain management and tissue regeneration progresses, the plantar fasciitis treatment market is poised for sustained development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Medication Therapy
  • Orthotics
  • Shockwave Therapy
  • Surgery
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Center
  • Clinics
  • Others

COMPANIES PROFILED

  • Pfizer Inc, Algeo Ltd, Otto bock SE Co, Hanger Inc, Bayer, GlaxoSmithKline Plc, Superfeet Worldwide Inc, Bauerfeid AG, KGaA Otto bock Holding, Sanofi, Group Dr Scholls
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Medication Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Orthotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Shockwave Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ambulatory Surgical Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PLANTAR FASCIITIS TREATMENT INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Pfizer Inc
    • 8.2.2 Algeo Ltd
    • 8.2.3 Otto Bock SE & Co
    • 8.2.4 Hanger Inc
    • 8.2.5 Bayer
    • 8.2.6 GlaxoSmithKline Plc
    • 8.2.7 Superfeet Worldwide Inc
    • 8.2.8 Bauerfeid AG
    • 8.2.9 KGaA (Otto Bock Holding)
    • 8.2.10 Sanofi
    • 8.2.11 Group (Dr. Scholl'S)